Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| Publicat a: | Springer eBooK. |
|---|---|
| Autor corporatiu: | |
| Altres autors: | |
| Format: | Electronic Resource |
| Idioma: | English |
| Publicat: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| Col·lecció: | Issues in children's and families' lives
no.2 |
| Matèries: | |
| Accés en línia: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |